134 related articles for article (PubMed ID: 8401415)
1. Platelet activity and salt sensitivity in the pathogenesis of systemic (essential) hypertension in black Africans.
Somova L; Mufunda J
Clin Exp Hypertens; 1993 Sep; 15(5):781-96. PubMed ID: 8401415
[TBL] [Abstract][Full Text] [Related]
2. The effect of prazosin therapy on platelet activation in essential hypertension.
Okrucká A; Pechán J; Mikulecký M
Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):813-9. PubMed ID: 2151184
[TBL] [Abstract][Full Text] [Related]
3. Effect of sodium restriction on platelet function in patients with essential hypertension.
Ikeda T; Gomi T; Sakurai J; Toya Y; Fujinami K; Yuhara M; Ikegami F
Jpn Heart J; 1989 May; 30(3):365-73. PubMed ID: 2529381
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure responses to dietary salt in rural and urban African men.
Mufunda J; Fink GD; Sparks HV
Ethn Dis; 1993; 3 Suppl():S46-58. PubMed ID: 8087023
[TBL] [Abstract][Full Text] [Related]
5. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
[TBL] [Abstract][Full Text] [Related]
7. Different platelet aggregability during mental stress in two stages of essential hypertension.
Tomoda F; Takata M; Kagitani S; Kinuno H; Yasumoto K; Tomita S; Inoue H
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1063-70. PubMed ID: 10604481
[TBL] [Abstract][Full Text] [Related]
8. Platelet calcium and quenched-flow aggregation kinetics in essential hypertension.
Taylor MA; Ayers CR; Gear AR
Hypertension; 1989 Jun; 13(6 Pt 1):558-66. PubMed ID: 2525522
[TBL] [Abstract][Full Text] [Related]
9. Effects of adrenaline infusion on serum thromboxane B2 and plasma beta-thromboglobulin levels in hypertensive and normotensive subjects.
Douma S; Zamboulis C; Karagiannis A; Sinakos Z
Nouv Rev Fr Hematol (1978); 1992; 34(1):73-8. PubMed ID: 1387933
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests.
Gresele P; Catalano M; Giammarresi C; Volpato R; Termini R; Ciabattoni G; Nenci GG; Davì G
Thromb Haemost; 1997 Dec; 78(6):1434-7. PubMed ID: 9423790
[TBL] [Abstract][Full Text] [Related]
11. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
[TBL] [Abstract][Full Text] [Related]
12. Influence of salt intake on the daytime-nighttime blood pressure variation in normotensive and hypertensive black subjects.
Damasceno A; Caupers P; Santos A; Lobo E; Sevene E; Bicho M; Polónia J
Rev Port Cardiol; 2000 Mar; 19(3):315-29. PubMed ID: 10804778
[TBL] [Abstract][Full Text] [Related]
13. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
Zatta A; Zanetti A; Dejana E; Prosdocimi M
Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218
[TBL] [Abstract][Full Text] [Related]
14. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy.
Okrucká A; Pechán J; Mikulecký M
Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological mechanisms of urbanisation-related hypertension and the sodium pressor response in black Zimbabweans.
Mufunda J; Somova L; Chifamba J
S Afr Med J; 1993 Jul; 83(7):507-10. PubMed ID: 8211492
[TBL] [Abstract][Full Text] [Related]
16. Effects of the calcium antagonist nifedipine on thromboxane B2 level and platelet aggregation in hypertensive patients.
Uehara S; Handa H; Hirayama A
Arzneimittelforschung; 1986 Nov; 36(11):1687-9. PubMed ID: 3814228
[TBL] [Abstract][Full Text] [Related]
17. Calcium supplementation attenuates an enhanced platelet function in salt-loaded mildly hypertensive patients.
Saito K; Sano H; Kawahara J; Yokoyama M
Hypertension; 1995 Jul; 26(1):156-63. PubMed ID: 7607719
[TBL] [Abstract][Full Text] [Related]
18. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
Rust P; Ekmekcioglu C
Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
[TBL] [Abstract][Full Text] [Related]
19. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein enhances platelet activation in parallel with the height of blood pressure.
Fetkovska N; Amstein R; Ferracin F; Bühler FR; Pletscher A
J Hypertens Suppl; 1988 Dec; 6(4):S646-8. PubMed ID: 3241277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
